Search Results - "Bowman, W P"

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031 by Schultz, K R, Carroll, A, Heerema, N A, Bowman, W P, Aledo, A, Slayton, W B, Sather, H, Devidas, M, Zheng, H W, Davies, S M, Gaynon, P S, Trigg, M, Rutledge, R, Jorstad, D, Winick, N, Borowitz, M J, Hunger, S P, Carroll, W L, Camitta, B

“…We previously reported preliminary findings that post induction imatinib mesylate (340 mg/m 2 /day), in combination with intensive chemotherapy, resulted in…”
Get full text

Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia by Liu, C, Kawedia, J D, Cheng, C, Pei, D, Fernandez, C A, Cai, X, Crews, K R, Kaste, S C, Panetta, J C, Bowman, W P, Jeha, S, Sandlund, J T, Evans, W E, Pui, C-H, Relling, M V

“…Hypersensitivity to asparaginase is common, but the differential diagnosis can be challenging and the diagnostic utility of antibody tests is unclear. We…”
Get full text

Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic Leukemia by Yang, Jun J, Cheng, Cheng, Yang, Wenjian, Pei, Deqing, Cao, Xueyuan, Fan, Yiping, Pounds, Stanley B, Neale, Geoffrey, Treviño, Lisa R, French, Deborah, Campana, Dario, Downing, James R, Evans, William E, Pui, Ching-Hon, Devidas, Meenakshi, Bowman, W. P, Camitta, Bruce M, Willman, Cheryl L, Davies, Stella M, Borowitz, Michael J, Carroll, William L, Hunger, Stephen P, Relling, Mary V

“…CONTEXT Pediatric acute lymphoblastic leukemia (ALL) is the prototype for a drug-responsive malignancy. Although cure rates exceed 80%, considerable…”
Get full text

A revised definition for cure of childhood acute lymphoblastic leukemia by Pui, C H, Pei, D, Campana, D, Cheng, C, Sandlund, J T, Bowman, W P, Hudson, M M, Ribeiro, R C, Raimondi, S C, Jeha, S, Howard, S C, Bhojwani, D, Inaba, H, Rubnitz, J E, Metzger, M L, Gruber, T A, Coustan-Smith, E, Downing, J R, Leung, W H, Relling, M V, Evans, W E

“…With improved contemporary therapy, we reassess long-term outcome in patients completing treatment for childhood acute lymphoblastic leukemia (ALL) to…”
Get full text

ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy by Bhojwani, D, Pei, D, Sandlund, J T, Jeha, S, Ribeiro, R C, Rubnitz, J E, Raimondi, S C, Shurtleff, S, Onciu, M, Cheng, C, Coustan-Smith, E, Bowman, W P, Howard, S C, Metzger, M L, Inaba, H, Leung, W, Evans, W E, Campana, D, Relling, M V, Pui, C-H

“…ETV6-RUNX1 fusion is the most common genetic aberration in childhood acute lymphoblastic leukemia (ALL). To evaluate whether outcomes for this drug-sensitive…”
Get full text

Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children’s Oncology Group Study AALL0031 by Schultz, K R, Devidas, M, Bowman, W P, Aledo, A, Slayton, W B, Sather, H, Zheng, H W, Davies, S M, Gaynon, P S, Trigg, M, Rutledge, R, Jorstad, D, Carroll, A J, Heerema, N, Winick, N, Borowitz, M J, Hunger, S P, Carroll, W L, Camitta, B

Get full text

Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy by Pui, C-H, Pei, D, Raimondi, S C, Coustan-Smith, E, Jeha, S, Cheng, C, Bowman, W P, Sandlund, J T, Ribeiro, R C, Rubnitz, J E, Inaba, H, Gruber, T A, Leung, W H, Yang, J J, Downing, J R, Evans, W E, Relling, M V, Campana, D

“…To determine the clinical significance of minimal residual disease (MRD) in patients with prognostically relevant subtypes of childhood acute lymphoblastic…”
Get full text

Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study by Bowman, W P, Shuster, J J, Cook, B, Griffin, T, Behm, F, Pullen, J, Link, M, Head, D, Carroll, A, Berard, C, Murphy, S

“…In an effort to improve outcome for children with advanced B-cell malignancies, a treatment plan based on a published regimen that consists of four courses of…”
Get more information

Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide by Winick, N J, McKenna, R W, Shuster, J J, Schneider, N R, Borowitz, M J, Bowman, W P, Jacaruso, D, Kamen, B A, Buchanan, G R

“…To describe the occurrence of secondary acute myeloid leukemia (AML) in children with acute lymphoblastic leukemia (ALL) treated with etoposide (VP-16). Two…”
Get more information

Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia by Farrow, A C, Buchanan, G R, Zwiener, R J, Bowman, W P, Winick, N J

“…The clinical significance of methotrexate (MTX)-induced hepatic toxicity in children with acute lymphoblastic leukemia (ALL) is poorly defined. Therefore, we…”
Get more information

Brexit: The influence of motivation to respond without prejudice, willingness to disagree, and attitudes to immigration by Bowman, Jonathan W. P., West, Keon

“…Britain’s unexpected vote to leave the European Union (Brexit) in June 2016 has proved divisive and damaging both within the United Kingdom and…”
Get full text

Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia by Winick, N, Shuster, J J, Bowman, W P, Borowitz, M, Farrow, A, Jacaruso, D, Buchanan, G R, Kamen, B A

“…To describe the use of combination chemotherapy, including divided-dose oral methotrexate (dMTX), for children with B-precursor acute lymphoblastic leukemia…”
Get more information

Universal Inactivation of Both p16 and p15 but not Downstream Components Is an Essential Event in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia by OMURA-MINAMISAWA, M, DICCIANNI, M. B, BATOVA, A, CHANG, R. C, BRIDGEMAN, L. J, YU, J, PULLEN, J, BOWMAN, W. P, YU, A. L

“…p16/p15 regulate the cell cycle pathway by inhibiting the cyclin Ds-CDK4/6 mediated phosphorylation of pRb. We reported previously that in T-cell acute…”
Get full text

Therapeutic trial for infant acute lymphoblastic leukemia : The Pediatric Oncology Group experience (POG 8493) by FRANKEL, L. S, OCHS, J, SHUSTER, J. J, DUBOWY, R, BOWMAN, W. P, HOCKENBERRY-EATON, M, BOROWITZ, M, CARROLL, A. J, STEUBER, C. P, PULLEN, D. J

“…Despite improved event-free survival of older children with acute lymphocytic leukemia (ALL), infants <1 year of age continue to have a very poor prognosis. A…”
Get full text

Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia by Winick, N J, Bowman, W P, Kamen, B A, Roach, E S, Rollins, N, Jacaruso, D, Buchanan, G R

“…Our current protocol for treatment of childhood acute lymphoblastic leukemia (ALL) was designed to assess the efficacy of methotrexate (MTX) plus…”
Get more information

Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine by Murphy, S B, Bowman, W P, Abromowitch, M, Mirro, J, Ochs, J, Rivera, G, Pui, C H, Fairclough, D, Berard, C W

“…To address the problem of historically poor results in the treatment of children with advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic…”
Get more information

Prognostic Importance of Blast Cell DNA Content in Childhood Acute Lymphoblastic Leukemia by Look, A. Thomas, Roberson, Paula K., Williams, Dorothy L., Rivera, Gaston, Bowman, W. Paul, Pui, Ching-Hon, Ochs, Judith, Abromowitch, Minnie, Kalwinsky, David, Dahl, Gary V., George, Stephen, Murphy, Sharon B.

“…Using flow cytometric techniques, we determined the pretreatment distribution of DNA content in propidium iodide-stained leukemic blasts from 205 children with…”
Get full text

Treatment of children with epipodophyllotoxin‐induced secondary acute myeloid leukemia by Sandler, Eric S., Friedman, David J., Mustafa, Mahmoud M., Winick, Naomi J., Bowman, W. Paul, Buchanan, George R.

“…BACKGROUND Secondary acute myeloid leukemia (AML) after treatment with epipodophyllotoxins is being observed with increased frequency. Therapeutic options are…”
Get full text

Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect by Evans, W E, Crom, W R, Abromowitch, M, Dodge, R, Look, A T, Bowman, W P, George, S L, Pui, C H

“…High-dose methotrexate (500 to 33,600 mg per square meter of body-surface area) with leucovorin rescue is a common component of therapy for acute lymphocytic…”
Get more information

Prime and prejudice: Brief stereotypical media representations can increase prejudicial attitudes and behaviour towards people with schizophrenia by Bowman, Jonathan W.P., West, Keon

“…Prejudice against people with mental illnesses remains a significant problem in the United Kingdom and in many other countries despite sustained efforts by…”
Get full text